Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Clinical trial NCT06161532 · RECRUITING

Trial details

NCT number: NCT06161532
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Carcinoma of the Bladder Small Cell Carcinoma of the Urinary Tract Squamous Cell Carcinoma of the Bladder Squamous Cell Carcinoma of the Urinary Tract Primary Adenocarcinoma of the Bladder Primary Adenocarcinoma of the Urinary Tract Renal Medullary Carcinoma Squamous Cell Carcinoma of the Penis

Start date: 2024-08-01
Primary completion: 2027-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.